HCM Treatment Market: Can "Genetic Cascade Screening" Stop Sudden Cardiac Death Before It Happens?
A major 2026 public health shift is the move toward "cascade screening," where the discovery of a genetic mutation in one HCM patient leads to the immediate testing of all first-degree relatives. In 2026, genetic testing has become so affordable and accurate that it is now a standard recommendation for any family with a history of unexplained heart failure or sudden death. This 2026 movement is...
0 Yorumlar 0 hisse senetleri 173 Views 0 önizleme
Sponsorluk